Cited by 894Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

Open access

Bergenstal, Richard M., Tamborlane, William V., Ahmann, Andrew, Buse, John B., Dailey, George, Davis, Stephen N., Joyce, Carol, Peoples, Tim, Perkins, Bruce A., Welsh, John B., Willi, Steven M., Wood, Michael A.·2010·New England Journal of Medicine

DOI 10.1056/nejmoa1002853

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Recently developed technologies for the treatment of type 1 diabetes mellitus include a variety of pumps and pumps with glucose sensors. METHODS: In this 1-year, multicenter, randomized, controlled trial, we compared the efficacy of sensor-augmented pump therapy (pump therapy) with that of a regimen of multiple daily insulin injections (injection therapy) in 485 patients (329 adults and 156 children) with inadequately controlled type 1 diabetes. Patients received recombinant insulin analogues and were supervised by expert clinical teams. The primary end point was the change from the baseline glycated hemoglobin level. RESULTS: At 1 year, the baseline mean glycated hemoglobin level (8.3% in the two study groups) had decreased to 7.5% in the pump-therapy group, as compared with 8.1% in the injection-therapy group (P<0.001). The proportion of patients who reached the glycated hemoglobin target (<7%) was greater in the pump-therapy group than in the injection-therapy group. The rate of severe hypoglycemia in the pump-therapy group (13.31 cases per 100 person-years) did not differ significantly from that in the injection-therapy group (13.48 per 100 person-years, P=0.58). There was no significant weight gain in either group. CONCLUSIONS: In both adults and children with inadequately controlled type 1 diabetes, sensor-augmented pump therapy resulted in significant improvement in glycated hemoglobin levels, as compared with injection therapy. A significantly greater proportion of both adults and children in the pump-therapy group than in the injection-therapy group reached the target glycated hemoglobin level. (Funded by Medtronic and others; ClinicalTrials.gov number, NCT00417989.)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1002853

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial
(1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70190-3 · Cited by 1,654
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Insulin analogues
Hirsch, I. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040832 · Cited by 667
Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005)
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion
Pickup, J. C., & Sutton, A. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02486.x · Cited by 630
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus
Misso, M. L., Egberts, K. J., Page, M., O'Connor, D., & Shaw, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005103.pub2 · Cited by 406
Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study
Hirsch, I. B., Abelseth, J. M., Bode, B. W., Fischer, J. S., KAUFMAN, F. R., Mastrototaro, J. J., Parkin, C. G., Wolpert, H. A., & Buckingham, B. A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0068 · Cited by 297
Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0889 · Cited by 250

Show all 12 references

Research works printed but not linked: 2

Misso ML, 2010, Cochrane Database Syst Rev, 1, CD005103
Hermanides J, 2009, Diabetologia, 52, S43

Sorted by citations

Items 401–500 of 894

Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy
Polsky, S., GIORDANO, D. A., Voelmle, M. K., Garcetti, R., & Garg, S. K. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1159910 · Cited by 16
Detecting failures of the glucose sensor-insulin pump system: Improved overnight safety monitoring for Type-1 diabetes
Facchinetti, A., Favero, S. D., Sparacino, G., & Cobelli, C. (2011) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2011.6091226 · Cited by 16
Redundancy in Glucose Sensing
Sharifi, A., Varsavsky, A., Ulloa, J., Horsburgh, J. C., McAuley, S. A., Krishnamurthy, B., Jenkins, A. J., Colman, P. G., Ward, G. M., MacIsaac, R. J., et al. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815612096 · Cited by 16
Predicting hypoglycemia in diabetic patients using data mining techniques
Eljil, K. S., Qadah, G. Z., & Pasquier, M. (2013) · International Conference on Innovations in Information Technology · doi:10.1109/innovations.2013.6544406 · Cited by 16
Therapie des Typ-1-Diabetes
Böhm, B., Dreyer, M., Fritsche, A., Füchtenbusch, M., Gölz, S., & Martin, S. (2012) · Diabetologie und Stoffwechsel · doi:10.1055/s-0032-1325579 · Cited by 16
Beneficios clínicos y económicos de la terapia con bomba de insulina integrada a sistema de monitoreo continuo de glucosa en los pacientes diabéticos tipo 1 en Colombia
Gómez, A. M., Alfonso‐Cristancho, R., Orozco, J. J., Lynch, P. M., Prieto, D., Saunders, R., Roze, S., & Valencia, J. E. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.05.011 · Cited by 17
Clinical Outcomes After 1 Year of Augmented Insulin Pump Therapy in Patients with Diabetes in a Specialized Diabetes Center in Medellín, Colombia
Rincón, A. R., Hincapié-García, J. A., Monsalve, C., Aristizábal, N., Castillo, E., Hincapie, G., Zapata, E., Cuesta, D., Delgado, M., Abad, V., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0166 · Cited by 17
Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII)
Nauck, M. A., Lindmeyer, A. M., Mathieu, C., & Meier, J. J. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819882752 · Cited by 17
Blood glucose regulation and control of insulin and glucagon infusion using single model predictive control for type 1 diabetes mellitus
Dias, C. C., Kamath, S. R., & Vidyasagar, S. (2020) · IET Systems Biology · doi:10.1049/iet-syb.2019.0101 · Cited by 16
Impulsive MPC schemes for biomedical processes: Application to type 1 diabetes
Rivadeneira, P. S., Godoy, J. L., Sereno, J. E., Abuin, P., Ferramosca, A., & González, A. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817461-6.00003-2 · Cited by 16
Glycaemic variabilities: Key questions in pursuit of clarity
Monnier, L., Owens, D. R., Colette, C., & Bonnet, F. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101283 · Cited by 16
Insulin therapy for the treatment of type 1 diabetes during pregnancy
Lenhard, M. J., & Kinsley, B. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.864631 · Cited by 16
Switching from treatment with sensor augmented pump to hybrid closed loop system in type 1 diabetes: impact on glycemic control and neuropsychological tests in the real world
Amigó, J., Ortiz-Zúñiga, Á., de Urbina, A. M. O., Sánchez, M., Dos-Santos, M., Abad, M., Cuadra, F., Simó, R., Hernández, C., & Simó-Servat, O. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110730 · Cited by 15
Baseline Predictors of A1C Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy: The STAR 3 Experience
Buse, J. B., DAILEY, G. E., Ahmann, A., Bergenstal, R. M., Green, J. B., Peoples, T., Tanenberg, R. J., & Yang, Q. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0225 · Cited by 15
Closed-loop artificial pancreas
WEINZIMER, S. A. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283514e6b · Cited by 14
Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study
Dejgaard, T. F., Knop, F. K., Tarnow, L., Frandsen, C. S., Hansen, T. S., Almdal, T., Holst, J. J., Madsbad, S., & Andersen, H. U. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007791 · Cited by 15
An Amperometric Glucose Sensor Integrated into an Insulin Delivery Cannula: In Vitro and In Vivo Evaluation
Ward, W. K., Heinrich, G., Breen, M. E., Benware, S., Vollum, N., Morris, K., Knutsen, C., Kowalski, J. D., Campbell, S., Biehler, J., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0407 · Cited by 15
Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol
Musolino, G., Allen, J. M., Hartnell, S., Wilinska, M. E., Tauschmann, M., Boughton, C. K., Campbell, F., Denvir, L., Trevelyan, N., Wadwa, P., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027856 · Cited by 14
A Reinforcement Learning Based System for Blood Glucose Control without Carbohydrate Estimation in Type 1 Diabetes: In Silico Validation
Hettiarachchi, C., Malagutti, N., Nolan, C. J., Daskalaki, E., & Suominen, H. (2022) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc48229.2022.9871054 · Cited by 18
Monitoring Glycemia in Diabetes
Healy, S. J., & Dungan, K. M. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.017 · Cited by 17
Crossing the Technology Divide
Rubin, R. R., Borgman, S. K., & Sulik, B. (2011) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721710391107 · Cited by 15
Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis
Guo, K., Li, J., Liyin, Z., Ye, J., Fan, L., Ding, Z., Qin, Z., Li, X., Lin, Y., & Zhou, Z. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.990281 · Cited by 14
Comparative Effectiveness of Hybrid Closed-Loop Automated Insulin Delivery Systems Among Patients with Type 1 Diabetes
Folk, S. Y. L., Zappe, J., Wyne, K. L., & Dungan, K. M. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241234948 · Cited by 14
Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to Advanced Hybrid Closed-Loop systems: a one-year real-life experience
Resmini, E., Zarra, E., Dotti, S., Rotondi, G., Cornaghi, A. V., Madaschi, S., Cimino, E., Massari, G., Pezzaioli, L. C., Buoso, C., et al. (2024) · European journal of medical research · doi:10.1186/s40001-024-01946-w · Cited by 14
Challenges and progress in the development of a closed-loop artificial pancreas
Bequette, B. W. (2012) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.1109/acc.2012.6315593 · Cited by 14
Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia
Gómez, A. M., Alfonso‐Cristancho, R., Orozco, J. J., Lynch, P. M., Prieto, D., Saunders, R., Roze, S., & Valencia, J. E. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.10.009 · Cited by 15
Patient Values and Preferences Regarding Continuous Subcutaneous Insulin Infusion and Artificial Pancreas in Adults with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Data
Múñoz, Ó., Guyatt, G. H., Devji, T., Zhang, Y., Li, S., Alexander, P. E., Henao, D. C., Gomez, A.-M., & Ruiz, Á. J. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0346 · Cited by 14
The Impact of Technology on Current Diabetes Management
Garvey, K. C., & Wolfsdorf, J. I. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.04.005 · Cited by 14
Patient Behaviors Associated with Optimum Glycemic Outcomes with Sensor-Augmented Pump Therapy: Insights from The Star 3 Study
Tanenberg, R. J., & Welsh, J. B. (2014) · Endocrine Practice · doi:10.4158/ep14187.or · Cited by 14
Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes
Welsh, J. B. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0100 · Cited by 14
Impact of insulin pump therapy on glycemic control among adult Saudi type-1 diabetic patients. An interview-based case-control study
Almogbel, E. S. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_869_19 · Cited by 14
Diabetes mellitus
Sperling, M. A., Tamborlane, W. V., Battelino, T., WEINZIMER, S. A., & Phillip, M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00028-7 · Cited by 16
Insulin Pump Therapy With Automated Insulin Suspension
Choudhary, P. (2013) · JAMA · doi:10.1001/jama.2013.278576 · Cited by 14
Outcome Measures for Outpatient Hypoglycemia Prevention Studies
Beck, R. W., Kollman, C., Xing, D., Buckingham, B. A., & Chase, H. P. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500423 · Cited by 14
Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery
Weiss, R., Garg, S. K., Bergenstal, R. M., Klonoff, D. C., Bode, B. W., Bailey, T. S., Thrasher, J. R., Schwartz, F., Welsh, J. B., KAUFMAN, F. R., et al. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815586014 · Cited by 12
From pancreatic extracts to artificial pancreas: History, science and controversies about the discovery of the pancreatic antidiabetic hormone
de Leiva, A., de Leiva-Pérez, A., & Brugués, E. (2011) · Avances en Diabetología · doi:10.1016/s1134-3230(11)70004-7 · Cited by 13
Future Perspectives in Glucose Monitoring Sensors
Frontino, G., Meschi, F., Bonfanti, R., Rigamonti, A., Battaglino, R., Favalli, V., Bonura, C., Ferro, G., & Chiumello, G. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2013.09.01.21 · Cited by 13
Diabetes Management in Transition: Market Insights and Technological Advancements in CGM and Insulin Delivery
Yu, T. S., Song, S., Yea, J., & Jang, K. (2024) · Advanced Sensor Research · doi:10.1002/adsr.202400048 · Cited by 14
Evidence for continuous glucose monitoring: sufficient for reimbursement?
Heinemann, L., & DeVries, J. H. (2013) · Diabetic Medicine · doi:10.1111/dme.12341 · Cited by 14
Automatic adaptation of basal therapy for Type 1 diabetic patients: a Run-to-Run approach
Toffanin, C., Sandri, A., Messori, M., Cobelli, C., & Magni, L. (2014) · IFAC Proceedings Volumes · doi:10.3182/20140824-6-za-1003.02462 · Cited by 12
Continuous glucose monitoring: coming of age?
DeVries, J. H. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1127 · Cited by 12
Automated Insulin Delivery—The Light at the End of the Tunnel
Turksoy, K., Frantz, N., Quinn, L., Dumin, M., Kilkus, J. M., Hibner, B. A., Çınar, A., & Littlejohn, E. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.02.055 · Cited by 12
Profile of a population-based diabetic macular oedema study: the Liverpool Eye and Diabetes Study (Sydney)
Liew, G., Wong, V. W., Saw, M., Tsang, T. E., Nolan, T., Ong, S., & Ho, I. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-021884 · Cited by 11
Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia
van Beers, C. A. J., Kleijer, S. J., Serné, E. H., Geelhoed-Duijvestijn, P. H. L. M., Snoek, F. J., Kramer, M. H. H., & Diamant, M. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0040-3 · Cited by 12
Hypoglycaemia, a global cause for concern
Heller, S. R., Amiel, S. A., & Khunti, K. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.11.004 · Cited by 12
A Study of the Carbohydrate-to-Insulin Ratio in Pregnant Women with Type 1 Diabetes on Pump Treatment
Bongiovanni, M., Fresa, R., Visalli, N., Bitterman, O., SURACI, C., & Napoli, A. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0246 · Cited by 12
Effect of switching from conventional continuous subcutaneous insulin infusion to sensor augmented pump therapy on glycemic profile in Japanese patients with type 1 diabetes
Matsuoka, A., Hirota, Y., Urai, S., Hamaguchi, T., Takeuchi, T., Miura, H., Otowa‐Suematsu, N., So, A., Nakamura, T., Komada, H., et al. (2018) · Diabetology International · doi:10.1007/s13340-018-0344-4 · Cited by 12
Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey
Roze, S., Smith‐Palmer, J., de Portu, S., Saltik, A. Z. O., Akgül, T., & Deyneli, O. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0198 · Cited by 12
Integrating an Islet-Based Biosensor in the Artificial Pancreas: In Silico Proof-of-Concept
Olçomendy, L., Pirog, A., Lebreton, F., Jaffredo, M., Cassany, L., Gucik‐Derigny, D., Cieslak, J., Henry, D., Lang, J., Catargi, B., et al. (2021) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2021.3109096 · Cited by 14
Continuous Glucose Monitoring for Glycemic Control in Children and Adolescents Diagnosed with Diabetes Type 1: A Systematic Review and Meta-Analysis
Dorando, E., Haak, T., & Pieper, D. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1268-0967 · Cited by 12
Children with type 1 diabetes in COVID-19 pandemic: Difficulties and solutions
Shi, Y., Wu, L., Wei, P., & Liao, Z. (2022) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v11.i5.408 · Cited by 12
Predicting Hypoglycemia in Diabetic Patients Using Time-Sensitive Artificial Neural Networks
Eljil, K. S., Qadah, G. Z., & Pasquier, M. (2016) · International Journal of Healthcare Information Systems and Informatics · doi:10.4018/ijhisi.2016100104 · Cited by 13
Clinical Requirements for Closed-Loop Control Systems
Clarke, W. L., & Renard, É. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600233 · Cited by 14
Addressing disparities in technology use among patients with type 1 diabetes: a review
Kanbour, S., & Everett, E. M. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000840 · Cited by 12
Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population: The RESCUE-pediatrics study
Ridder, F. D., Charleer, S., Jacobs, S., Bolsens, N., Ledeganck, K. J., Aken, S. V., Vanbesien, J., Gies, I., Casteels, K., Massa, G., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.991633 · Cited by 11
Effects of hybrid closed‐loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor‐augmented pump: A prospective single‐center observational study
Akiyama, T., Yamakawa, T., Orime, K., Ichikawa, M., Harada, M., Netsu, T., Akamatsu, R., Nakamura, K., Shinoda, S., & Terauchi, Y. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14103 · Cited by 11
Lessons Learned From a Pilot RCT of Simultaneous Versus Delayed Initiation of Continuous Glucose Monitoring in Children and Adolescents With Type 1 Diabetes Starting Insulin Pump Therapy
Olivier, P., Lawson, M. L., Huot, C., Richardson, C., Nakhla, M. M., & Romain, J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814524855 · Cited by 11
Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy
Majithia, A. R., Wiltschko, A. B., Zheng, H., Walford, G. A., & Nathan, D. M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817725756 · Cited by 11
Documento de posicionamiento sobre la eficiencia de las tecnologías aplicadas al manejo de la diabetes
Martín-Vaquero, P., Martínez‐Brocca, M. A., & López, J. M. G. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.08.003 · Cited by 11
Contested Daily Routines, Contested Care. Children with Type 1 Diabetes in Covid-19 Times
Şahinol, M., & BAŞKAVAK, G. (2021) · Childhood Vulnerability Journal · doi:10.1007/s41255-021-00017-0 · Cited by 11
Detecting hypoglycemia by using the brain as a biosensor
Madsen, R. E., Remvig, L. S., Beck‐Nielsen, H., & Juhl, C. B. (2011) · InTech eBooks · doi:10.5772/17018 · Cited by 11
Bénéfices de l’insulinothérapie par pompe chez les enfants diabétiques de type 1
Hasselmann, C., Bonnemaison, É., Faure, N., Mercat, I., Pépin-Donat, M., Magontier, N., Chantepie, A., & Labarthe, F. (2012) · Archives de Pédiatrie · doi:10.1016/j.arcped.2012.03.051 · Cited by 11
Regenerative Surgery: Tissue Engineering in General Surgical Practice
Wong, V., Wan, D. C., Gurtner, G. C., & Longaker, M. T. (2012) · World Journal of Surgery · doi:10.1007/s00268-012-1710-1 · Cited by 11
Comparison Between Sensor-Augmented Insulin Therapy with Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections in Everyday Life: 3-Day Analysis of Glucose Patterns and Sensor Accuracy in Children
Zucchini, S., Scipione, M., Balsamo, C., Maltoni, G., Rollo, A., Molinari, E., Mangoni, L., & Cicognani, A. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0080 · Cited by 13
Effectiveness of continuous glucose monitoring in children, adolescents, and young adults with poorly controlled type 1 diabetes
Lewis, K. R., McCrone, S., Deiriggi, P., & Bendre, S. V. (2016) · Journal for Specialists in Pediatric Nursing · doi:10.1111/jspn.12162 · Cited by 11
Intermittently scanned continuous glucose monitoring provides no benefit over structured self-monitoring of blood glucose in type 2 diabetes not on prandial insulin, in the context of diabetes self-management education: GLucose monitoring programme SingaporE (GLiMPSE)
Rama Chandran, S., Rahman, N., Gandhi, M., Tan, N. C., Phoon, I. K. Y., Seah, D. E. J., Cheah, M. H., Sek, K., & Gardner, D. S.-L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111678 · Cited by 10
Exploring Technology’s Influence on Health Behaviours and Well-being in Type 1 Diabetes: a Review
McClure, R. D., Talbo, M. K., Bonhoure, A., Molveau, J., South, C. A., Lebbar, M., & Wu, Z. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01534-6 · Cited by 16
Risk predictors of glycaemic control in children and adolescents with type 1 diabetes: A systematic review and meta‐analysis
Gangqiang, G., Chen, H., & Sun, H. (2024) · Journal of Clinical Nursing · doi:10.1111/jocn.17110 · Cited by 10
Recent Advances in the Prevention of Hypoglycemia in Type 1 Diabetes
Realsen, J., & Chase, H. P. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0150 · Cited by 10
Efficacy and safety of the artificial pancreas in the paediatric population with type 1 diabetes
Esposito, S., Santi, E., Mancini, G., Rogari, F., Tascini, G., Toni, G., Argentiero, A., & Berioli, M. G. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1558-8 · Cited by 10
Continuous Subcutaneous Insulin Infusions: Closing the Loop
Díaz-Balzac, C. A., Pillinger, D., & Wittlin, S. D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac746 · Cited by 10
Intensive diabetes management and goal setting are key aspects of improving metabolic control in children and young people with type 1 diabetes mellitus
Soni, A. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.877 · Cited by 10
Hypoglycemia and Blood Glucose Fluctuations in the Application of a Sensor-Augmented Insulin Pump
Luo, P., Cheng, Q., Chen, B., Li, Y., Wu, J., Zhang, X., Jiao, X., Zhao, J., & Lv, X. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0078 · Cited by 10
Real-Time Continuous Glucose Monitoring or Continuous Subcutaneous Insulin Infusion, What Goes First?: Results of a Pilot Study
Moreno-Fernández, J., Gómez, F. J., Gazquez, M., Pedroche, M., García‐Manzanares, Á., Tenías, J. M., Benito, P., & Gomez, I. R. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0033 · Cited by 10
Continuous Glucose Monitoring in Pregnancy: New Frontiers in Clinical Applications and Research
Sung, J. F., Taslimi, M. M., & Faig, J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600629 · Cited by 10
The Contemporary Role of Masked Continuous Glucose Monitoring in a Real-Time World
Blumer, I. R. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815619182 · Cited by 10
Type 1 Diabetes Mellitus
Inzucchi, S. E., & Sherwin, R. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00236-0 · Cited by 10
Influence on Measurement Signal by Pressure and Viscosity Changes of Fluid and Installation Condition of FBG Sensor Using Blood Flow Simulation Model
Koyama, S., Hayase, T., MIYAUCHI, S., SHIRAI, A., Chino, S., Haseda, Y., & Ishizawa, H. (2019) · IEEE Sensors Journal · doi:10.1109/jsen.2019.2938243 · Cited by 10
Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles
Tweden, K. S., Deiss, D., Rastogi, R., Addaguduru, S., & KAUFMAN, F. R. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0342 · Cited by 10
Treatment of diabetic mice by microfluidic system-assisted transplantation of stem cells-derived insulin-producing cells transduced with miRNA
Soltani, A., Soleimani, M., Ghiass, M. A., Enderami, S. E., Rabbani, S., Jafarian, A., & Allameh, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119338 · Cited by 10
Letting the World See through Your Eyes: Using Photovoice to Explore the Role of Technology in Physical Activity for Adolescents Living with Type 1 Diabetes
Morrow, D., Kirk, A. F., Muirhead, F., & Lennon, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19106315 · Cited by 10
Continuous Glucose Monitoring in Children and Adolescents
Slover, R. H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0303-6 · Cited by 10
Benefits of Blinded Continuous Glucose Monitoring during a Randomized Clinical Trial
Muchmore, D. B., Sharp, M., & Vaughn, D. E. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500321 · Cited by 10
Potential of education‐based insulin therapy for achievement of good metabolic control: a real‐life experience
Albrecht, D., Puder, J. J., Keller, U. B., & Zulewski, H. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03260.x · Cited by 10
Can Improved Glycemic Control Slow Renal Function Decline at All Stages of Diabetic Nephropathy?
Goel, G., & Perkins, B. A. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.07.004 · Cited by 10
Diabetes mellitus: a complete ancient and modern historical perspective
Nwaneri, C. (2015) · Cited by 10
The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study
Katayama, A., Tone, A., Watanabe, M., Teshigawara, S., Miyamoto, S., Eguchi, J., Nakatsuka, A., Shikata, K., & Wada, J. (2019) · Diabetology International · doi:10.1007/s13340-019-00408-7 · Cited by 10
Continuous Glucose Monitoring for the Internist
Lee, G. S., & Lupsa, B. C. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.004 · Cited by 9
Metabolic Outcomes in Pediatric Patients One-Year Post-Total Pancreatectomy with Islet Autotransplantation after Early Pump Initiation
TELLEZ, S. E., Hornung, L. N., Abu‐El‐Haija, M. A., & Elder, D. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093319 · Cited by 9
Recognition, Prevention, and Proactive Management of Hypoglycemia in Patients with Type 1 Diabetes Mellitus
Unger, J., & Parkin, C. G. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2306 · Cited by 9
Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons
Maiorino, M. I., Petrizzo, M., Bellastella, G., & Esposito, K. (2017) · Endocrine · doi:10.1007/s12020-017-1328-z · Cited by 9
Modern clinical management helps reducing the impact of type 1 diabetes in children
Scaramuzza, A. E., & Zuccotti, G. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.001 · Cited by 9
Are Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies?
Price, D. A., Graham, C., Parkin, C. G., & Peyser, T. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815607863 · Cited by 9
Management of Diabetes in Children
Wolfsdorf, J. I., & Garvey, K. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00049-4 · Cited by 9
Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus‐basal insulin regimens: A n analysis from the OpT2mise randomized trial
Metzger, M., Castañeda, J., Reznik, Y., Giorgino, F., Conget, I., Aronson, R., de Portu, S., Runzis, S., Lee, S. W., & Cohen, O. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12960 · Cited by 9
The clinician factor: Personality characteristics of clinicians and their impact upon clinical outcomes in the management of children and adolescents with type 1 diabetes
Cameron, F. J., Russell, E., McCombe, J., O’Connell, M. A., & Skinner, T. C. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12646 · Cited by 9
Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes
de Valk, H. W., Lablanche, S., Bosi, E., Choudhary, P., Silva, J. D., Castañeda, J., Vorrink, L., de Portu, S., & Cohen, O. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0222 · Cited by 9
Chemical modification of proteins with photocleavable groups
Nadendla, K., Sarode, B. R., & Friedman, S. H. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.04.008 · Cited by 9
Has subsidized continuous glucose monitoring improved outcomes in pediatric diabetes?
Swaney, E. E. K., McCombe, J., Coggan, B., Donath, S. M., O’Connell, M. A., & Cameron, F. J. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13106 · Cited by 9
Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan
Ishibashi, R., Baba, Y., Kakinuma, K., Takasaki, A., Hiraga, C., Harama, T., Yamamoto, T., Nakamura, S., Koshizaka, M., Maezawa, Y., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00971-2 · Cited by 8

Authors: Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., Willi, S. M., & Wood, M. A.
Affiliations: Park Nicollet Health Services (US)
Yale University (US)
Oregon Health & Science University (US)
University of North Carolina at Chapel Hill (US)
University of Maryland, Baltimore (US)
Memorial University of Newfoundland (CA)
Toronto General Hospital (CA)
Children's Hospital of Philadelphia (US)
Helen DeVos Children's Hospital (US)
ORCID: Bergenstal, Richard M.
Tamborlane, William V.
Ahmann, Andrew
Buse, John B.
Dailey, George
Davis, Stephen N.
Perkins, Bruce A.
Welsh, John B.
Willi, Steven M.
Wood, Michael A.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2010-07-22
Volume: 363
Issue: 4
Pages: 311-320
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1002853
OpenAlex: W2142433802
Cited by: 894
References: 12
Citations by year: 2026: 18 · 2025: 25 · 2024: 38 · 2023: 28 · 2022: 41 · 2021: 50 · 2020: 43 · 2019: 55 · 2018: 66 · 2017: 62 · 2016: 71 · 2015: 78 · 2014: 63 · 2013: 65 · 2012: 88
FWCI: 61.06
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
UNC Libraries
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079637)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: type 1 diabetes, sensor-augmented insulin pump therapy, multiple daily insulin injections, HbA1c, glycemic control, hypoglycemia, insulin analogues, children and adults, weight gain
MeSH terms: Adolescent, Adult, Analysis of Variance, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Middle Aged, Diabetic Ketoacidosis, Treatment Outcome, Monitoring, Ambulatory, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks